184 related articles for article (PubMed ID: 27863504)
1. B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.
Bruijnen S; Tsang-A-Sjoe M; Raterman H; Ramwadhdoebe T; Vugts D; van Dongen G; Huisman M; Hoekstra O; Tak PP; Voskuyl A; van der Laken C
Arthritis Res Ther; 2016 Nov; 18(1):266. PubMed ID: 27863504
[TBL] [Abstract][Full Text] [Related]
2. PET/CT Imaging of Human TNFα Using [
Beckford-Vera DR; Gonzalez-Junca A; Janneck JS; Huynh TL; Blecha JE; Seo Y; Li X; VanBrocklin HF; Franc BL
Mol Imaging Biol; 2020 Feb; 22(1):105-114. PubMed ID: 31065895
[TBL] [Abstract][Full Text] [Related]
3. CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.
Tran L; Huitema AD; van Rijswijk MH; Dinant HJ; Baars JW; Beijnen JH; Vogel WV
Hum Antibodies; 2011; 20(1-2):29-35. PubMed ID: 21558621
[TBL] [Abstract][Full Text] [Related]
4. Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment.
Vital EM; Dass S; Rawstron AC; Buch MH; Goëb V; Henshaw K; Ponchel F; Emery P
Arthritis Rheum; 2010 May; 62(5):1273-9. PubMed ID: 20131284
[TBL] [Abstract][Full Text] [Related]
5. A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study.
Stradner MH; Dejaco C; Brickmann K; Graninger WB; Brezinschek HP
Arthritis Res Ther; 2016 Aug; 18(1):190. PubMed ID: 27558631
[TBL] [Abstract][Full Text] [Related]
6. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies.
Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM
Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871
[TBL] [Abstract][Full Text] [Related]
7. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Humby F; Durez P; Buch MH; Lewis MJ; Rizvi H; Rivellese F; Nerviani A; Giorli G; Mahto A; Montecucco C; Lauwerys B; Ng N; Ho P; Bombardieri M; Romão VC; Verschueren P; Kelly S; Sainaghi PP; Gendi N; Dasgupta B; Cauli A; Reynolds P; Cañete JD; Moots R; Taylor PC; Edwards CJ; Isaacs J; Sasieni P; Choy E; Pitzalis C;
Lancet; 2021 Jan; 397(10271):305-317. PubMed ID: 33485455
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging of Liposomal Glucocorticoids using
Gawne PJ; Clarke F; Turjeman K; Cope AP; Long NJ; Barenholz Y; Terry SYA; de Rosales RTM
Theranostics; 2020; 10(9):3867-3879. PubMed ID: 32226525
[TBL] [Abstract][Full Text] [Related]
9. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis.
Ramwadhdoebe TH; van Baarsen LGM; Boumans MJH; Bruijnen STG; Safy M; Berger FH; Semmelink JF; van der Laken CJ; Gerlag DM; Thurlings RM; Tak PP
Rheumatology (Oxford); 2019 Jun; 58(6):1075-1085. PubMed ID: 30649469
[TBL] [Abstract][Full Text] [Related]
10. Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire.
Pollastro S; Klarenbeek PL; Doorenspleet ME; van Schaik BDC; Esveldt REE; Thurlings RM; Boumans MJH; Gerlag DM; Tak PP; Vos K; Baas F; van Kampen AHC; de Vries N
Ann Rheum Dis; 2019 Oct; 78(10):1339-1345. PubMed ID: 31217169
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET.
Verweij N; Zwezerijnen G; Ter Wee M; de Jongh J; Yaqub M; van Schaardenburg D; Lammertsma A; Voskuyl A; Lems W; Boers M; van der Laken C
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35149604
[TBL] [Abstract][Full Text] [Related]
12. Tumor uptake and tumor/blood ratios for [
Al-Saden N; Cai Z; Reilly RM
Nucl Med Biol; 2018 Dec; 67():43-51. PubMed ID: 30390575
[TBL] [Abstract][Full Text] [Related]
13. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
Front Immunol; 2019; 10():2437. PubMed ID: 31681317
[No Abstract] [Full Text] [Related]
14. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?
Valor L; Martínez-Estupiñán L; Janta I; Nieto JC; Ovalles-Bonilla JG; González-Fernández C; Del Rio T; Hernández-Flórez D; Monteagudo I; López-Longo FJ; Naredo E
Rheumatol Int; 2016 Jun; 36(6):793-7. PubMed ID: 27072348
[TBL] [Abstract][Full Text] [Related]
16. F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach.
Bruijnen STG; Chandrupatla DMSH; Giovanonni L; Neri D; Vugts DJ; Huisman MC; Hoekstra OS; Musters RJP; Lammertsma AA; van Dongen GAMS; Jansen G; Molthoff CFM; van der Laken CJ
Mol Pharm; 2019 Jan; 16(1):273-281. PubMed ID: 30550295
[TBL] [Abstract][Full Text] [Related]
17. Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis.
Kavanal AJ; Bhattacharya A; Sharma A; Shukla J; Chattopadhyay A; M B A; Sharma V; Vatsa R; Rana N; Kaur G; Mittal BR
Clin Nucl Med; 2021 Jul; 46(7):556-561. PubMed ID: 33782288
[TBL] [Abstract][Full Text] [Related]
18. The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
Fabris M; Quartuccio L; Vital E; Pontarini E; Salvin S; Fabro C; Zabotti A; Benucci M; Manfredi M; Ravagnani V; Biasi D; Atzeni F; Sarzi-Puttini P; Morassi P; Fischetti F; Bazzicchi L; Saracco M; Pellerito R; Cimmino M; Carraro V; Semeraro A; Schiavon F; Caporali R; Bortolotti R; Govoni M; Fogolari F; Tonutti E; Bombardieri S; Emery P; De Vita S
Arthritis Rheum; 2013 Jan; 65(1):88-97. PubMed ID: 23001900
[TBL] [Abstract][Full Text] [Related]
19. Radiation Dosimetry Study of [(89)Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography.
Natarajan A; Gambhir SS
Mol Imaging Biol; 2015 Aug; 17(4):539-47. PubMed ID: 25500766
[TBL] [Abstract][Full Text] [Related]
20. Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion.
Váncsa A; Szabó Z; Szamosi S; Bodnár N; Végh E; Gergely L; Szucs G; Szántó S; Szekanecz Z
J Rheumatol; 2013 May; 40(5):565-71. PubMed ID: 23547216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
